drugset / Trial / NCT01556607

A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma

NCT01556607 ↗

Phase 1 Completed 10 enrolled MicroDose Therapeutx, Inc
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to assess the safety and tolerability of MDT-637, when inhaled by subjects with Intermittent, or Mild-to-Moderate Persistent, Asthma.

Timeline

Start
2012-03
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator VP-14637 Small molecule — Inhaled

Indications

No indication recorded.